Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex322.htm |
| EX-32.1 - EXHIBIT 32.1 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex321.htm |
| EX-31.2 - EXHIBIT 31.2 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex312.htm |
| EX-31.1 - EXHIBIT 31.1 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex311.htm |
| EX-21.1 - EXHIBIT 21.1 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex211.htm |
| 10-K - 10-K - GENOCEA BIOSCIENCES, INC. | gnca-20161231x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-194021) pertaining to the Amended and Restated 2007 Equity Incentive Plan and 2014 Equity Incentive Plan of Genocea Biosciences, Inc., |
(2) | Registration Statement (Form S-8 No. 333-197127) pertaining to the 2014 Employee Stock Purchase Plan of Genocea Biosciences, Inc., |
(3) | Registration Statement (Form S-3 No. 333-203981) of Genocea Biosciences, Inc., and |
(4) | Registration Statement (Form S-8 No. 333-209576) pertaining to the 2014 Equity Incentive Plan of Genocea Biosciences, Inc.; |
of our report dated February 17, 2017, with respect to the financial statements of Genocea Biosciences, Inc. included in this Annual Report (Form 10-K) of Genocea Biosciences, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP
Boston, Massachusetts
February 17, 2017